Literature DB >> 20236124

De novo duplication of MECP2 in a girl with mental retardation and no obvious dysmorphic features.

P Makrythanasis1, I Moix, S Gimelli, J Fluss, K Aliferis, S E Antonarakis, M A Morris, F Béna, A Bottani.   

Abstract

Loss-of-function mutations of MECP2 are responsible for Rett syndrome (RTT), an X-linked neurodevelopmental disorder affecting mainly girls. The availability of MECP2 testing has led to the identification of such mutations in girls with atypical RTT features and the recognition of milder forms. Furthermore, duplication of the entire gene has recently been described in boys with mental retardation and recurrent infections. We describe a girl with a heterozygous de novo MECP2 duplication. The patient, at the age of 19, has mental retardation with no autistic features. She is friendly but gets frequently anxious. She has neither dysmorphic features nor malformations. Her motor development was delayed with walking at 20 months. Speech is fluid with good pronunciation but is simple and repetitive. Diagnosis was made after single-strand conformation analysis (SSCA) and multiplex ligation-dependent probe amplification (MLPA) analysis of MECP2. Array comparative genomic hybridization (aCGH) analysis showed a duplication of 29 kb including MECP2 and part of IRAK1. Fluorescent in situ hybridization (FISH) has revealed that the duplicated region is inserted near the telomere of the short arm of chromosome 10. X-chromosome inactivation in leukocyte DNA was not skewed. We conclude that it is likely that this MECP2 duplication is responsible for the mental retardation in this patient. This case broadens the phenotypic spectrum of MECP2 abnormalities with consequent implication in diagnosis and genetic counselling of girls with non-syndromic mental retardation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236124     DOI: 10.1111/j.1399-0004.2010.01371.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

1.  MECP2 Duplication Syndrome.

Authors:  H Van Esch
Journal:  Mol Syndromol       Date:  2011-07-05

2.  De novo MECP2 duplication in two females with random X-inactivation and moderate mental retardation.

Authors:  Ute Grasshoff; Michael Bonin; Ina Goehring; Arif Ekici; Andreas Dufke; Kirsten Cremer; Nicholas Wagner; Eva Rossier; Anna Jauch; Michael Walter; Claudia Bauer; Peter Bauer; Karl Horber; Stefanie Beck-Woedl; Dagmar Wieczorek
Journal:  Eur J Hum Genet       Date:  2011-02-16       Impact factor: 4.246

3.  De novo MECP2 duplications in two females with intellectual disability and unfavorable complete skewed X-inactivation.

Authors:  Nathalie Fieremans; Marijke Bauters; Stefanie Belet; Jelle Verbeeck; Anna C Jansen; Sara Seneca; Filip Roelens; Elfride De Baere; Peter Marynen; Guy Froyen
Journal:  Hum Genet       Date:  2014-07-19       Impact factor: 4.132

4.  Xq28 duplications including MECP2 in five females: Expanding the phenotype to severe mental retardation.

Authors:  E K Bijlsma; A Collins; F T Papa; M I Tejada; P Wheeler; E A J Peeters; A C J Gijsbers; J M van de Kamp; M Kriek; M Losekoot; A J Broekma; J A Crolla; M Pollazzon; M Mucciolo; E Katzaki; V Disciglio; M I Ferreri; A Marozza; M A Mencarelli; C Castagnini; L Dosa; F Ariani; F Mari; R Canitano; G Hayek; M P Botella; B Gener; M Mínguez; A Renieri; C A L Ruivenkamp
Journal:  Eur J Med Genet       Date:  2012-03-29       Impact factor: 2.708

5.  MECP2 Duplications in Symptomatic Females: Report on 3 Patients Showing the Broad Phenotypic Spectrum.

Authors:  Victoria San Antonio-Arce; María Fenollar-Cortés; Raluca Oancea Ionescu; Teresa DeSantos-Moreno; Jesús Gallego-Merlo; Francisco José Illana Cámara; María Carmen Cotarelo Pérez
Journal:  Child Neurol Open       Date:  2016-04-04

6.  A sibship with duplication of Xq28 inherited from the mother; genomic characterization and clinical outcomes.

Authors:  Dong Keon Yon; Ji Eun Park; Seung Jun Kim; Sung Han Shim; Kyu Young Chae
Journal:  BMC Med Genet       Date:  2017-03-17       Impact factor: 2.103

7.  Infectious and immunologic phenotype of MECP2 duplication syndrome.

Authors:  Michael Bauer; Uwe Kölsch; Renate Krüger; Nadine Unterwalder; Karin Hameister; Fabian Marc Kaiser; Aglaia Vignoli; Rainer Rossi; Maria Pilar Botella; Magdalena Budisteanu; Monica Rosello; Carmen Orellana; Maria Isabel Tejada; Sorina Mihaela Papuc; Oliver Patat; Sophie Julia; Renaud Touraine; Thusari Gomes; Kirsten Wenner; Xiu Xu; Alexandra Afenjar; Annick Toutain; Nicole Philip; Aleksandra Jezela-Stanek; Ludwig Gortner; Francisco Martinez; Bernard Echenne; Volker Wahn; Christian Meisel; Dagmar Wieczorek; Salima El-Chehadeh; Hilde Van Esch; Horst von Bernuth
Journal:  J Clin Immunol       Date:  2015-02-27       Impact factor: 8.317

Review 8.  A brief history of MECP2 duplication syndrome: 20-years of clinical understanding.

Authors:  Daniel Ta; Jenny Downs; Gareth Baynam; Andrew Wilson; Peter Richmond; Helen Leonard
Journal:  Orphanet J Rare Dis       Date:  2022-03-21       Impact factor: 4.123

9.  A partial MECP2 duplication in a mildly affected adult male: a putative role for the 3' untranslated region in the MECP2 duplication phenotype.

Authors:  Neil A Hanchard; Claudia M B Carvalho; Patricia Bader; Aaron Thome; Lisa Omo-Griffith; Daniela del Gaudio; Davut Pehlivan; Ping Fang; Christian P Schaaf; Melissa B Ramocki; James R Lupski; Sau Wai Cheung
Journal:  BMC Med Genet       Date:  2012-08-10       Impact factor: 2.103

10.  MECP2 duplication phenotype in symptomatic females: report of three further cases.

Authors:  Francesca Novara; Alessandro Simonati; Federico Sicca; Roberta Battini; Simona Fiori; Annarita Contaldo; Lucia Criscuolo; Orsetta Zuffardi; Roberto Ciccone
Journal:  Mol Cytogenet       Date:  2014-01-28       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.